Hepatology Digest: in terms of biomarkers we are still struggling to find specific candidates for this cancer.

Hepatology Digest: Due to the lack of good biomarkers does alpha-fetoprotein have any utility in terms of detecting those who have higher risk of liver cancer?

In this paper we reviewed the advances of the common markers as well as the detection methods in laboratory diagnosis of liver cancer at home and abroad, and forecasts its developmental prospect.